Measure | Patients with STD Eligibility | ||||
---|---|---|---|---|---|
With CVERP | Without CVERP | p-value | |||
N = 21,006 | N = 21,006 |  | |||
n/mean | %/SD | n/mean | %/SD | Â | |
During the 1st month of follow-up: | Â | Â | Â | Â | Â |
Patients reporting STD (n, %) | 8,764 | 41.7 | 1,011 | 4.8 | <.001 |
Monthly hours lost due to STD (mean, SD) | 57.7 | 74.6 | 6.0 | 29.7 | <.001 |
Indirect costs associated with STD (mean, SD) | $996 | $1,309 | $102 | $506 | <.001 |
Patients with ≥ 1 year of follow-up (n, %) | 12,632 | 60.1 | 13,527 | 64.4 |  |
During the 1st year of follow-up: | Â | Â | Â | Â | Â |
Patients reporting STD (n, %) | 5,890 | 46.6 | 1,406 | 10.4 | <.001 |
Monthly hours lost due to STD (mean, SD) | 16.3 | 30.8 | 3.6 | 16.7 | <.001 |
Indirect costs associated with STD (mean, SD) | $281 | $529 | $60 | $278 | <.001 |
Patients with ≥ 2 years of follow-up (n, %) | 7,196 | 34.3 | 8,038 | 38.3 |  |
During the 2nd year of follow-up: | Â | Â | Â | Â | Â |
Patients reporting STD (n, %) | 1,031 | 14.3 | 734 | 9.1 | <.001 |
Monthly hours lost due to STD (mean, SD) | 4.7 | 18.0 | 2.7 | 13.3 | <.001 |
Indirect costs associated with STD (mean, SD) | $79 | $308 | $45 | $219 | <.001 |
Patients with ≥ 3 years of follow-up (n, %) | 3,984 | 19.0 | 4,635 | 22.1 |  |
During the 3rd year of follow-up: | Â | Â | Â | Â | Â |
Patients reporting STD (n, %) | 536 | 13.5 | 364 | 7.9 | <.001 |
Monthly hours lost due to STD (mean, SD) | 4.4 | 17.9 | 2.1 | 10.8 | <.001 |
Indirect costs associated with STD (mean, SD) | $73 | $298 | $34 | $177 | <.001 |